{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T22:28:30Z","timestamp":1788215310164,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.exer.2023.109750","type":"journal-article","created":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T21:16:25Z","timestamp":1702415785000},"page":"109750","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["IL1R2 promotes retinal angiogenesis to participate in retinopathy of prematurity by activating the HIF1\u03b1\/PFKFB3 pathway"],"prefix":"10.1016","volume":"239","author":[{"given":"Na","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4806-4679","authenticated-orcid":false,"given":"Qiaolian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2023.109750_bib1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/s-0040-1713181","article-title":"Update in the treatment of retinopathy of prematurity","volume":"39","author":"Bancalari","year":"2022","journal-title":"AM J PERINAT"},{"key":"10.1016\/j.exer.2023.109750_bib3","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.smim.2013.10.023","article-title":"The interleukin-1 receptor family","volume":"25","author":"Boraschi","year":"2013","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.exer.2023.109750_bib4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/aos.12049","article-title":"The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge","volume":"92","author":"Cavallaro","year":"2014","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.exer.2023.109750_bib5","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/0167-5699(94)90217-8","article-title":"The type II 'decoy' receptor: a novel regulatory pathway for interleukin 1","volume":"15","author":"Colotta","year":"1994","journal-title":"Immunol. Today"},{"key":"10.1016\/j.exer.2023.109750_bib6","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1038\/nprot.2009.187","article-title":"Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis","volume":"4","author":"Connor","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.exer.2023.109750_bib7","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0888-7543(91)90219-5","article-title":"Chromosomal location of murine and human IL-1 receptor genes","volume":"9","author":"Copeland","year":"1991","journal-title":"Genomics"},{"key":"10.1016\/j.exer.2023.109750_bib8","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/ppe.12810","article-title":"Incidence of retinopathy of prematurity treatment in extremely preterm infants in China","volume":"36","author":"Dai","year":"2022","journal-title":"PAEDIATR PERINAT EP"},{"key":"10.1016\/j.exer.2023.109750_bib9","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","article-title":"Interleukin-1 in the pathogenesis and treatment of inflammatory diseases","volume":"117","author":"Dinarello","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exer.2023.109750_bib10","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/j.1460-9568.2005.03965.x","article-title":"Differential regulation of type I and type II interleukin-1 receptors in focal brain inflammation","volume":"21","author":"Docagne","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.exer.2023.109750_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0278857","article-title":"The impact of modifier genes on cone-rod dystrophy heterogeneity: an explorative familial pilot study and a hypothesis on neurotransmission impairment","volume":"17","author":"Donato","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2023.109750_bib12","article-title":"Epitranscriptome analysis of oxidative stressed retinal epithelial cells depicted a possible RNA editing landscape of retinal degeneration","volume":"11","author":"Donato","year":"2022","journal-title":"ANTIOXIDANTS-BASEL"},{"key":"10.1016\/j.exer.2023.109750_bib13","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1007\/s11010-022-04394-4","article-title":"Retinopathy of prematurity: contribution of inflammatory and genetic factors","volume":"477","author":"Fevereiro-Martins","year":"2022","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.exer.2023.109750_bib14","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1742-2094-8-120","article-title":"Activation of retinal microglia rather than microglial cell density correlates with retinal neovascularization in the mouse model of oxygen-induced retinopathy","volume":"8","author":"Fischer","year":"2011","journal-title":"J NEUROINFLAMM"},{"key":"10.1016\/j.exer.2023.109750_bib15","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/j.ophtha.2019.11.026","article-title":"Retinopathy of prematurity incidence in children","volume":"127","author":"Good","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2023.109750_bib16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3345\/cep.2021.00773","article-title":"Retinopathy of prematurity: a review of epidemiology and current treatment strategies","volume":"65","author":"Hong","year":"2022","journal-title":"Clin Exp Pediatr"},{"key":"10.1016\/j.exer.2023.109750_bib17","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/01.RES.0000259593.07661.1e","article-title":"Endothelial cell migration during angiogenesis","volume":"100","author":"Lamalice","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.exer.2023.109750_bib18","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/0006-2952(90)90129-9","article-title":"Binding of aminoalkylphosphorothioate radioprotective drugs to rodent tissue proteins","volume":"39","author":"Livesey","year":"1990","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.exer.2023.109750_bib19","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1210\/clinem\/dgab362","article-title":"The role of HIF1alpha-PFKFB3 pathway in diabetic retinopathy","volume":"106","author":"Min","year":"2021","journal-title":"J CLIN ENDOCR METAB"},{"key":"10.1016\/j.exer.2023.109750_bib20","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/imr.12609","article-title":"Tuning inflammation and immunity by the negative regulators IL-1R2 and IL-1R8","volume":"281","author":"Molgora","year":"2018","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.exer.2023.109750_bib21","doi-asserted-by":"crossref","first-page":"53562","DOI":"10.1074\/jbc.M406096200","article-title":"6-Phosphofructo-2-kinase (pfkfb3) gene promoter contains hypoxia-inducible factor-1 binding sites necessary for transactivation in response to hypoxia","volume":"279","author":"Obach","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exer.2023.109750_bib22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/02713680590923276","article-title":"Increased expression of chemokine KC, an interleukin-8 homologue, in a model of oxygen-induced retinopathy","volume":"30","author":"Powers","year":"2005","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2023.109750_bib23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12974-017-0943-1","article-title":"Retinopathy of prematurity: inflammation, choroidal degeneration, and novel promising therapeutic strategies","volume":"14","author":"Rivera","year":"2017","journal-title":"J NEUROINFLAMM"},{"key":"10.1016\/j.exer.2023.109750_bib24","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1161\/ATVBAHA.113.301331","article-title":"Microglia and interleukin-1beta in ischemic retinopathy elicit microvascular degeneration through neuronal semaphorin-3A","volume":"33","author":"Rivera","year":"2013","journal-title":"ARTERIOSCL THROM VAS"},{"key":"10.1016\/j.exer.2023.109750_bib25","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-053924","article-title":"Retinopathy of prematurity: a global perspective and recent developments","volume":"150","author":"Sabri","year":"2022","journal-title":"Pediatrics"},{"key":"10.1016\/j.exer.2023.109750_bib26","first-page":"D9734","article-title":"Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity","volume":"1","author":"Sankar","year":"2018","journal-title":"COCHRANE DB SYST REV"},{"key":"10.1016\/j.exer.2023.109750_bib27","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12881-016-0332-0","article-title":"CCM3\/SERPINI1 bidirectional promoter variants in patients with cerebral cavernous malformations: a molecular and functional study","volume":"17","author":"Scimone","year":"2016","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.exer.2023.109750_bib28","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3389\/fgene.2020.00146","article-title":"High-throughput sequencing to detect novel likely gene-disrupting variants in pathogenesis of sporadic brain arteriovenous malformations","volume":"11","author":"Scimone","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.exer.2023.109750_bib29","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10072-018-3674-x","article-title":"Vis-a-vis: a focus on genetic features of cerebral cavernous malformations and brain arteriovenous malformations pathogenesis","volume":"40","author":"Scimone","year":"2019","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.exer.2023.109750_bib30","first-page":"416","article-title":"Oxygen-induced retinopathy: a model for vascular pathology in the retina","volume":"24","author":"Scott","year":"2010","journal-title":"Early Years Educat."},{"key":"10.1016\/j.exer.2023.109750_bib31","article-title":"Propranolol ameliorates retinopathy of prematurity in mice by downregulating HIF-1alpha via the PI3K\/Akt\/ERK pathway","author":"Su","year":"2022","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.exer.2023.109750_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2021.101018","article-title":"Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF)","volume":"88","author":"Tsai","year":"2022","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.exer.2023.109750_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20174321","article-title":"Vascular and neuronal protection in the developing retina: potential therapeutic targets for retinopathy of prematurity","volume":"20","author":"Tsang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2023.109750_bib34","doi-asserted-by":"crossref","first-page":"e4778","DOI":"10.1210\/clinem\/dgab469","article-title":"The HIF1alpha-PFKFB3 pathway: a key player in diabetic retinopathy","volume":"106","author":"Vezza","year":"2021","journal-title":"J CLIN ENDOCR METAB"},{"key":"10.1016\/j.exer.2023.109750_bib35","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2174\/092986710790149783","article-title":"Hypoxia-inducible factor-1 as regulator of angiogenesis in rheumatoid arthritis - therapeutic implications","volume":"17","author":"Westra","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.exer.2023.109750_bib36","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.3389\/fimmu.2019.01618","article-title":"IL-1 family members mediate cell death, inflammation and angiogenesis in retinal degenerative diseases","volume":"10","author":"Wooff","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.exer.2023.109750_bib37","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.immuni.2013.01.008","article-title":"Intracellular interleukin-1 receptor 2 binding prevents cleavage and activity of interleukin-1alpha, controlling necrosis-induced sterile inflammation","volume":"38","author":"Zheng","year":"2013","journal-title":"Immunity"}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483523003718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483523003718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:35:47Z","timestamp":1762148147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483523003718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":36,"alternative-id":["S0014483523003718"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2023.109750","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL1R2 promotes retinal angiogenesis to participate in retinopathy of prematurity by activating the HIF1\u03b1\/PFKFB3 pathway","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2023.109750","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109750"}}